Get 40% Off
🔥 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

US STOCKS-Wall St little changed despite upbeat data

Published 08/26/2009, 12:17 PM
Updated 08/26/2009, 12:18 PM
DE
-
HGSI
-
GSK
-
DHI
-
CMI
-
PHM
-

* Durable goods post largest gain in two years

* New home sales rise at fastest pace since Sept 2008 (Updates to midday)

By Rodrigo Campos

NEW YORK, Aug 26 (Reuters) - U.S. stocks seesawed on Wednesday despite strong data on new home sales and durable goods orders as investors paused after a recent sharp run-up.

Sales of new homes rose in July to their fastest pace in 10 months, while orders for long-lasting manufactured goods surged, hinting a modest economic recovery was taking shape.

For the third consecutive day, equities briefly bounced after favorable news, but the gains fizzled.

"New home sales were better, but given the recent data we've had I don't think that was a surprise," said Michael James, senior trader at Wedbush Morgan in Los Angeles.

James said investor psychology is focusing "on the fact that we've had up moves and then sold off both Monday and Tuesday. After today's initial surge, buyers are becoming a little tired."

The Dow Jones industrial average shed 2.72 points, or 0.03 percent, to 9,536.57. The Standard & Poor's 500 Index fell 1.35 points, or 0.13 percent, to 1,026.65. The Nasdaq Composite Index dropped 6.13 points, or 0.30 percent, to 2,018.10.

The S&P 500 is on track for its sixth straight monthly rise, and has gained about 52 percent from 12-year lows set in early March.

Shares of machinery maker Cummins Inc fell 3.6 percent to $46.29, while peer Deere & Co lost 2.8 percent to $45.01, as the S&P industrials index shed 1 percent.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Homebuilder stocks were among the top gainers, with the Dow Jones home construction index up 2.3 percent. D.R. Horton Inc jumped 4.8 percent to $13.67, and Pulte Homes Inc gained 2.2 percent to $13.35.

On Nasdaq, Human Genome Sciences Inc rose 14.6 percent to $22.01 on continued speculation that GlaxoSmithKline Plc was set to pay a healthy premium for the company. A biotech stocks index rose 4.6 percent.

Buoyed by a surge in aircraft orders, durable goods orders jumped 5 percent, the largest advance since July 2007, after falling by a revised 1.3 percent in June, the government said.

Earlier, the Mortgage Bankers Association said U.S. mortgage applications rose for a second straight week, with demand for home refinancing loans rising to its highest level since early June.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.